Hyperphosphorylated Tau Aggregates and Multi-Target Combination Regimens
Rising understanding of neurodegenerative cascade kinetics, the high correlation between tau neurofibrillary tangles and cognitive decline, and clinical limitations of standalone amyloid clearing are driving investment in the Alzheimer’s Therapeutic Market. Tau protein misfolding and spreading directly drive synaptic loss and clinical dementia progression, making anti-tau monoclonal...
0 Commentarios 0 Acciones 180 Views 0 Vista previa